Neurobiological Technologies, Inc. (NTII)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Nov 14, 2025

NTII Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2009FY 2008FY 2007FY 2006FY 2005
Period Ending
Dec '09 Jun '09 Jun '08 Jun '07 Jun '06 Jun '05
25.3226.3514.7617.6712.343.1
Revenue Growth (YoY)
77.65%78.52%-16.48%43.23%298.10%11.23%
Gross Profit
25.3226.3514.7617.6712.343.1
Selling, General & Admin
4.095.086.886.545.974.93
Research & Development
1.7417.5824.5826.7422.8110.75
Operating Expenses
5.8322.6731.4633.2728.7815.68
Operating Income
19.493.68-16.7-15.6-16.44-12.58
Interest Expense
---2.48---
Interest & Investment Income
0.280.751.250.490.40.25
Other Non Operating Income (Expenses)
0-0.263.380.98--
EBT Excluding Unusual Items
19.774.18-14.54-14.13-16.04-12.33
Gain (Loss) on Sale of Investments
-0.83-0.86-1.78---
Asset Writedown
-0.19-0.19----
Pretax Income
18.723.12-16.32-14.13-27.54-24.98
Income Tax Expense
0.05---0.3-
Net Income
18.673.12-16.32-14.13-27.84-24.98
Net Income to Common
18.673.12-16.32-14.13-27.84-24.98
Shares Outstanding (Basic)
272719444
Shares Outstanding (Diluted)
272719444
Shares Change (YoY)
0.34%38.63%348.06%6.59%7.39%28.30%
EPS (Basic)
0.690.12-0.84-3.26-6.84-6.59
EPS (Diluted)
0.690.12-0.84-3.26-6.84-6.59
Free Cash Flow
-3.69-16.43-20.71-13.28.63-10.05
Free Cash Flow Per Share
-0.14-0.61-1.06-3.042.12-2.65
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
76.97%13.98%-113.12%-88.28%-133.21%-405.76%
Profit Margin
73.72%11.85%-110.58%-79.94%-225.62%-805.86%
Free Cash Flow Margin
-14.58%-62.36%-140.30%-74.67%69.92%-324.24%
EBITDA
19.543.82-16.49-15.37-16.24-12.5
EBITDA Margin
77.17%14.48%-111.73%-86.97%-131.64%-
D&A For EBITDA
0.050.130.210.230.190.07
EBIT
19.493.68-16.7-15.6-16.44-12.58
EBIT Margin
76.97%13.98%-113.12%-88.28%-133.21%-
Effective Tax Rate
0.28%-----
Revenue as Reported
25.3226.3514.7617.6712.343.1
Source: S&P Global Market Intelligence. Standard template. Financial Sources.